MEDX — medmix AG Cashflow Statement
0.000.00%
Last trade - 00:00
- CH₣620.70m
- CH₣848.80m
- CH₣486.60m
- 63
- 27
- 22
- 28
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 25.2 | 9.6 | 44 | 11.6 | 0.7 |
Depreciation | |||||
Non-Cash Items | 18.7 | 7.9 | 20.9 | 48.9 | 11.6 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 2.1 | -9.9 | -29.3 | -64.1 | -14.6 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 89.2 | 50.7 | 87.3 | 47.5 | 56.1 |
Capital Expenditures | -36.2 | -43.1 | -31.9 | -38.6 | -52.9 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -3.5 | 47.6 | 28.6 | -18.4 | -27.7 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Sale of Intangible Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -39.7 | 4.5 | -3.3 | -57 | -80.6 |
Financing Cash Flow Items | — | — | 0.9 | 0.2 | -1.7 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -59 | -42.9 | 112 | 116 | -154 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -11.8 | 10.5 | 195 | 104 | -183 |